Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report

BACKGROUND: Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. CASE PRESENTATION: A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with...

Descripción completa

Detalles Bibliográficos
Autores principales: Doran, Mehmet Ali, Aytogan, Hasan, Ayıntap, Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276213/
https://www.ncbi.nlm.nih.gov/pubmed/34256791
http://dx.doi.org/10.1186/s12985-021-01610-3
_version_ 1783721861995036672
author Doran, Mehmet Ali
Aytogan, Hasan
Ayıntap, Emre
author_facet Doran, Mehmet Ali
Aytogan, Hasan
Ayıntap, Emre
author_sort Doran, Mehmet Ali
collection PubMed
description BACKGROUND: Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. CASE PRESENTATION: A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant. CONCLUSION: We investigated the fluorescence of favipiravir tablets under ultraviolet light. Drug demonstrated fluorescence. We recorded the favipiravir fluorescence in-vitro. This appears to be a strong evidence in terms of the linkage between the fluorescence of the ocular surface and favipiravir.
format Online
Article
Text
id pubmed-8276213
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82762132021-07-14 Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report Doran, Mehmet Ali Aytogan, Hasan Ayıntap, Emre Virol J Case Report BACKGROUND: Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. CASE PRESENTATION: A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant. CONCLUSION: We investigated the fluorescence of favipiravir tablets under ultraviolet light. Drug demonstrated fluorescence. We recorded the favipiravir fluorescence in-vitro. This appears to be a strong evidence in terms of the linkage between the fluorescence of the ocular surface and favipiravir. BioMed Central 2021-07-13 /pmc/articles/PMC8276213/ /pubmed/34256791 http://dx.doi.org/10.1186/s12985-021-01610-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Doran, Mehmet Ali
Aytogan, Hasan
Ayıntap, Emre
Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title_full Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title_fullStr Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title_full_unstemmed Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title_short Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report
title_sort fluorescence of ocular surface in a covid -19 patient after favipiravir treatment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276213/
https://www.ncbi.nlm.nih.gov/pubmed/34256791
http://dx.doi.org/10.1186/s12985-021-01610-3
work_keys_str_mv AT doranmehmetali fluorescenceofocularsurfaceinacovid19patientafterfavipiravirtreatmentacasereport
AT aytoganhasan fluorescenceofocularsurfaceinacovid19patientafterfavipiravirtreatmentacasereport
AT ayıntapemre fluorescenceofocularsurfaceinacovid19patientafterfavipiravirtreatmentacasereport

Ejemplares similares